In summary, treatment with pea peptides can effectively reduce blood glucose levels and glucose tolerance in mice with high-fat-diet-induced obesity, regulating glucose metabolism through the IRS-1/PI3K/Akt signaling pathway. This evidence concerns the gene IRS1 and obesity due to melanocortin 4 receptor deficiency.